1
Main outcome measures: Serum HIV-1 antibody status and tuberculin skin test reactivity.
2
We present general means to greatly increase the sensitivity of antibody-based assays.
3
However, the difference of recognition mechanism between DHPS and antibody remains unknown.
4
However, whether anti-A13 antibody contributes to immune protection against orthopoxviruses was unknown.
5
The monoclonal antibody treatment reportedly used in treatments so far was experimental.
6
The antibody result indicates that each protofilament is asymmetric with different ends.
7
Therefore, B lymphocytes and antibody-secreting cells are considered relevant targets for therapies.
8
Enfortumab vedotin is a new type of treatment called an antibody-drug conjugate.
9
However, there was no correlation between the IgG3 antibody level and protection.
10
Positive antibody response was defined as ⩾-2-foldincreaseof pre-vaccination antibody levels.
11
Five years later, he developed severe OH, and anti-LGI1 antibody was positive.
12
There are currently two types of COVID-19 tests: active infection and antibody.
13
Results: Western blotting demonstrated that the monoclonal antibody was specific to pfetin.
14
Rapid antibody-based tests must be made universally available, and at no cost.
15
Overall, our results suggest a general reduction in serum IgM antibody responses.
16
This paper discusses the detection of antibody catalysis using soluble test substrates.
